MetrionAIResearch

Sign in Register

Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading market dashboard

My Watchlist

Sign in to track securities

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading news article

Back to markets

wsj.com/March 31, 2026 at 8:33 AMSLIM

Novo Nordisk Launches Discounted Subscription Program for Wegovy Obesity Drugs

The company is trying to win customers by offering a “lower, predictable monthly price” for its obesity drugs.

Open original source